Rani Therapeutics Holdings, Inc. Class A Common Stock
RANI Real Time Price USDRecent trades of RANI by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by RANI's directors and management
* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.
- 1M
- 3M
- 6M
- YTD
- 1Y
- 2Y
- 5Y
- MAX
About
Key Metrics
Return (1d)
Return (30d)
Return (1Y)
CAGR (Total)
Max Drawdown
Beta
Alpha
Sharpe Ratio
Win Rate
Average Win
Average Loss
Annual Volatility
Annual Std Dev
Information Ratio
Treynor Ratio
Total Trades
Metrics Definitions
-
Alpha
Measures a portfolio's risk-adjusted performance against that of its benchmark
Learn More -
Annual Standard Deviation
Measures how much the portfolio's total return varies from its mean or average.
Learn More -
Annual Volatility
A statistical measure of the dispersion of returns for the portfolio.
Learn More -
Average Win
The average return (%) for trades that resulted in a positive return.
-
Average Loss
The average return (%) for trades that resulted in a negative return.
-
Beta
A measure of the volatility of the portfolio compared to the market as a whole.
Learn More -
CAGR
CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.
Learn More -
Information Ratio
A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.
Learn More -
Max Drawdown
the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.
Learn More -
Sharpe Ratio
The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.
Learn More -
Total Trades
The total number of trades made by this strategy.
-
Treynor Ratio
Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.
Learn More -
Win Rate
The percentage of total trades that resulted in a positive return.
Be the first to see our newest insights and key updates across all datasets.
Government lobbying spending instances
Estimated quarterly lobbying spending
RANI Revenue by Segment or Geography
New patents grants
-
Patent Title: Swallowable drug delivery device and methods of drug delivery Apr. 08, 2025
-
Patent Title: Device, system and methods for the oral delivery of therapeutic compounds Apr. 01, 2025
-
Patent Title: Pharmaceutical compositions and methods for fabrication of solid masses comprising polypeptides and/or proteins Feb. 04, 2025
-
Patent Title: Clotting factor preparations for delivery into tissue of the intestinal tract using a swallowable drug delivery device Jan. 21, 2025
-
Patent Title: Ingestible device with expandable enclosure Oct. 29, 2024
-
Patent Title: Pcsk9 antibody preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device Jun. 25, 2024
-
Patent Title: Method of delivering insulin into a lumen of the intestinal tract using a swallowable drug delivery device Dec. 19, 2023
-
Patent Title: Propulsive drug delivery from a swallowable device into a patients intestinal tract Dec. 05, 2023
-
Patent Title: Clotting factor preparations for delivery into tissue of the intestinal tract using a swallowable drug delivery device Nov. 28, 2023
-
Patent Title: Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device Nov. 14, 2023
-
Patent Title: Method of delivering a somatostatin compound into a lumen of the intestinal tract using a swallowable drug delivery device Nov. 14, 2023
-
Patent Title: Device, system and methods for the oral delivery of therapeutic compounds Nov. 07, 2023
-
Patent Title: Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device Oct. 03, 2023
-
Patent Title: Pharmaceutical compositions and methods for fabrication of solid masses comprising polypeptides and/or proteins Aug. 08, 2023
-
Patent Title: Preparation comprising exanatide for delivery into a lumen of the intestinal tract Jun. 27, 2023
-
Patent Title: Method of delivering gonadotropin releasing hormone or an analogue thereof into a lumen of the intestinal tract using a swallowable drug delivery device May. 23, 2023
-
Patent Title: Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device May. 02, 2023
-
Patent Title: Devices, systems, and methods for delivering therapeutic agents into a stomach wall Jan. 31, 2023
-
Patent Title: Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device Jan. 17, 2023
-
Patent Title: Anti-interleukin antibody preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device Jan. 10, 2023
-
Patent Title: Clotting factor preparations for delivery into tissue of the intestinal tract using a swallowable drug delivery device Oct. 11, 2022
-
Patent Title: Methods for delivering etanercept preparations into a lumen of the intestinal tract using a swallowable drug delivery device Aug. 23, 2022
-
Patent Title: Therapeutic agent preparations into a lumen of the intestinal tract using a swallowable drug delivery device Jul. 05, 2022
-
Patent Title: Swallowable drug delivery device and methods of drug delivery May. 24, 2022
-
Patent Title: Pharmaceutical compositions and methods for fabrication of solid masses comprising polypeptides and/or proteins Apr. 19, 2022
-
Patent Title: Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device Apr. 19, 2022
-
Patent Title: Pharmaceutical compositions and methods for fabrication of solid masses comprising tnf-inhibiting antibodies Apr. 05, 2022
-
Patent Title: Swallowable drug delivery device and methods of drug delivery Feb. 22, 2022
-
Patent Title: Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device Jan. 25, 2022
-
Patent Title: Swallowable capsule, system and method for measuring gastric emptying parameters Aug. 31, 2021
-
Patent Title: Shaped mass composition comprising exenatide Jun. 08, 2021
-
Patent Title: Swallowable drug delivery device and method of delivery Apr. 27, 2021
-
Patent Title: Therapeutic preparation comprising insulin for delivery into a lumen of the intestinal tract using a swallowable drug delivery device Apr. 20, 2021
-
Patent Title: Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device Apr. 06, 2021
-
Patent Title: Method of delivering a somatostatin compound into a lumen of the intestinal tract using a swallowable drug delivery device Mar. 23, 2021
-
Patent Title: Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device Feb. 23, 2021
-
Patent Title: Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device Jan. 12, 2021
-
Patent Title: Preparation comprising exanatide for delivery into a lumen of the intestinal tract Dec. 29, 2020
-
Patent Title: Method of delivering gonadotropin releasing hormone or an analogue thereof into a lumen of the intestinal tract using a swallowable drug delivery device Dec. 15, 2020
-
Patent Title: Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device Aug. 25, 2020
-
Patent Title: Methods for delivering etanercept preparations into a lumen of the intestinal tract using a swallowable drug delivery device May. 05, 2020
-
Patent Title: Therapeutic agent preparations into a lumen of the intestinal tract using a swallowable drug delivery device Mar. 24, 2020
-
Patent Title: Therapeutic composition comprising insulin prepared for delivery into an intestinal tract Feb. 04, 2020
-
Patent Title: Therapeutic agent preparations into a lumen of the intestinal tract using a swallowable drug delivery device Dec. 03, 2019
-
Patent Title: Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device Nov. 26, 2019
-
Patent Title: Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device Nov. 19, 2019
-
Patent Title: Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device Jul. 16, 2019
-
Patent Title: Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device Jul. 02, 2019
-
Patent Title: Method of delivering gonadotropin releasing hormone or an analogue thereof into a lumen of the intestinal tract using a swallowable drug delivery device Jun. 18, 2019
-
Patent Title: Method of delivering a somatostatin compound into a lumen of the intestinal tract using a swallowable drug delivery device Jun. 11, 2019
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Recent insights relating to RANI
Recent picks made for RANI stock on CNBC
ETFs with the largest estimated holdings in RANI
- ... Highest Price Target
- ... Median Price Target
- ... Lowest Price Target
|
Analyst
|
Firm
|
Current
|
Previous
|
Date
|
|---|
- Is $RANI stock a Buy, Sell, or Hold?
- What is the price target for $RANI stock?
* Analyst consensus is not financial advice. Please see our data disclaimers .
|
Shareholder
|
Shares Held
|
|---|
- Who owns $RANI stock?
- Who owns the most shares of $RANI stock?
- What funds own $RANI stock?
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view RANI Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.